A 24-year-old woman comes to the emergency department because of a 4-hour history of headaches, nausea, and vomiting. During this time, she has also had recurrent dizziness and palpitations. The symptoms started while she was at a friend's birthday party, where she had one beer. One week ago, the patient was diagnosed with a genitourinary infection and started on antimicrobial therapy. She has no history of major medical illness. Her pulse is 106/min and blood pressure is 102/73 mm Hg. Physical examination shows facial flushing and profuse sweating. The patient is most likely experiencing adverse effects caused by treatment for an infection with which of the following pathogens?
Q122
A 40-year-old woman presents to clinic with multiple complaints. She complains of swelling around her eyes (Image A) and generalized weakness. A complete blood count reveals eosinophilia. She recently returned from a trip to Asia where she reports having eaten street food, including pork. If this patient's disease is explained by a parasite that causes inflammation of skeletal muscle, what would be the appropriate treatment?
Q123
A 56-year-old man with a history of HIV presents with diarrhea. The patient has had diarrhea for the past week and it has been gradually worsening. The patient describes it as profuse and watery. He has lost 15 pounds during this time frame and feels very weak. The patient is not currently taking his antiretroviral medications and historically has been non-compliant with his medications. His temperature is 98.5°F (36.9°C), blood pressure is 122/58 mmHg, pulse is 127/min, respirations are 14/min, and oxygen saturation is 99% on room air. Physical exam is notable for an emaciated man who is tachycardic. Stool exam with a modified acid-fast stain reveals organisms. The patient is started on IV fluids. Which of the following is the best treatment for this patient?
Q124
A 62-year-old woman presents to her oncologist to discuss the chemotherapy options for her newly diagnosed breast cancer. During the meeting, they discuss a drug that inhibits the breakdown of mitotic spindles in cells. Her oncologist explains that this will be more toxic to cancer cells because those cells are dividing more rapidly. Which of the following side effects is closely associated with the use of this chemotherapeutic agent?
Q125
A 32-year-old female presents to her gynecologist complaining of heavy and irregular vaginal bleeding. One month ago, she underwent a dilation and curettage procedure to remove a hydatidiform mole. On examination, her uterus appears enlarged. Serum ß-hCG is highly elevated. Biopsy of her uterus reveals avillous proliferation of cytotrophoblasts and syncytiotrophoblasts. She is eventually diagnosed with choriocarcinoma and initiates treatment with a medication known to affect folate metabolism. Which of the following complications should this patient most likely be monitored for following initiation of the medication?
Q126
A 67-year-old woman who was diagnosed with cancer 2 months ago presents to her oncologist with a 6-day history of numbness and tingling in her hands and feet. She is concerned that these symptoms may be related to progression of her cancer even though she has been faithfully following her chemotherapy regimen. She is not currently taking any other medications and has never previously experienced these symptoms. On physical exam, she is found to have decreased sensation to pinprick and fine touch over hands, wrists, ankles, and feet. Furthermore, she is found to have decreased reflexes throughout. Her oncologist assures her that these symptoms are a side effect from her chemotherapy regimen rather than progression of the cancer. The drug most likely responsible for her symptoms has which of the following mechanisms?
Q127
A 69-year-old male with past medical history of hypertension, hyperlipidemia, and diabetes mellitus complicated by end stage renal disease on dialysis presents to his nephrologist for a follow-up appointment. A few weeks ago, the patient saw his nephrologist because he had been feeling tired despite efforts to get enough sleep, eat a well-balanced diet, and exercise. At the time, laboratory studies revealed a hemoglobin of 9.7 g/dL, and the patient’s nephrologist suggested starting recombinant human erythropoietin (EPO). Since then, the patient has been receiving EPO intravenously three times per week. The patient reports today that he continues to feel tired despite the new treatment. His temperature is 98.0°F (36.7°C), blood pressure is 134/83 mmHg, pulse is 65/min, and respirations are 12/min. On physical exam, he has conjunctival pallor, and laboratory studies show a hemoglobin of 9.8 g/dL.
Which of the following laboratory findings would currently be seen in this patient?
Q128
A 23-year-old man is admitted to the hospital for observation because of a headache, dizziness, and nausea that started earlier in the day while he was working. He moves supplies for a refrigeration company and was handling a barrel of carbon tetrachloride before the symptoms began. He was not wearing a mask. One day after admission, he develops a fever and is confused. His temperature is 38.4°C (101.1°F). Serum studies show a creatinine concentration of 2.0 mg/dL and alanine aminotransferase concentration of 96 U/L. This patient's laboratory abnormalities are most likely due to which of the following processes?
Q129
A 15-year-old boy presents to the emergency department after a rusty nail pierced through his right foot. He was able to pull out the nail, but is unable to walk on his foot. He believes he had all his shots as a child, but his mother is unsure and cannot recall the specific vaccination dates or details. His last documented tetanus vaccination was at age 12. The vital signs are within normal limits. Physical examination reveals a 0.5-inch puncture wound on the right heel. The site is tender, erythematous, with flecks of reddish-brown particles in the base. No blood or discharge is seen. Which of the following is the most appropriate next step in management?
Q130
A 65-year-old man comes to the physician because of a 1-month history of progressive back pain. He has also had a 5-kg (11-lb) weight loss over the past 3 months. His only medications are a daily multivitamin and ibuprofen, which he takes daily for the back pain. Physical examination shows tenderness to palpation over the lower spine and the left iliac crest. His hemoglobin concentration is 9.3 g/dL, his serum calcium concentration is 12 mg/dL, and his serum creatinine concentration is 2.1 mg/dL. A bone marrow biopsy shows 21% plasma cells. A diagnosis of multiple myeloma is established. In preparation for an autologous hematopoietic stem cell transplantation, the patient receives a myeloablative treatment regimen that includes busulfan. Which of the following drugs acts via a similar mechanism of action to busulfan?
Antimicrobials US Medical PG Practice Questions and MCQs
Question 121: A 24-year-old woman comes to the emergency department because of a 4-hour history of headaches, nausea, and vomiting. During this time, she has also had recurrent dizziness and palpitations. The symptoms started while she was at a friend's birthday party, where she had one beer. One week ago, the patient was diagnosed with a genitourinary infection and started on antimicrobial therapy. She has no history of major medical illness. Her pulse is 106/min and blood pressure is 102/73 mm Hg. Physical examination shows facial flushing and profuse sweating. The patient is most likely experiencing adverse effects caused by treatment for an infection with which of the following pathogens?
A. Candida albicans
B. Chlamydia trachomatis
C. Neisseria gonorrhoeae
D. Herpes simplex virus
E. Trichomonas vaginalis (Correct Answer)
Explanation: ***Trichomonas vaginalis***
- The patient's symptoms (headache, nausea, vomiting, dizziness, palpitations, facial flushing, sweating) after consuming alcohol while on antimicrobial therapy for a genitourinary infection are characteristic of a **disulfiram-like reaction**.
- **Metronidazole**, a common treatment for *Trichomonas vaginalis* infection, is known to cause a disulfiram-like reaction when combined with alcohol, due to inhibition of **acetaldehyde dehydrogenase**.
*Candida albicans*
- Genitourinary infections with *Candida albicans* (e.g., vulvovaginal candidiasis) are typically treated with **antifungal medications** like fluconazole, which do not cause disulfiram-like reactions with alcohol.
- While symptoms like headache can occur with some antifungals, the constellation of flushing, palpitations, and nausea after a single beer strongly points away from this pathogen.
*Chlamydia trachomatis*
- *Chlamydia trachomatis* is commonly treated with **azithromycin** or **doxycycline**, neither of which are associated with disulfiram-like reactions to alcohol.
- The patient's symptoms are specific to alcohol interaction with certain antimicrobials, not typical side effects of these antibiotics.
*Neisseria gonorrhoeae*
- Infections with *Neisseria gonorrhoeae* are usually treated with **ceftriaxone** (often with azithromycin), which also do not cause disulfiram-like reactions.
- The clinical presentation after alcohol consumption is inconsistent with the typical adverse effects of these treatments.
*Herpes simplex virus*
- Genitourinary infections caused by herpes simplex virus are treated with **antiviral medications** such as acyclovir or valacyclovir.
- These antiviral drugs do not cause disulfiram-like reactions when ingested with alcohol.
Question 122: A 40-year-old woman presents to clinic with multiple complaints. She complains of swelling around her eyes (Image A) and generalized weakness. A complete blood count reveals eosinophilia. She recently returned from a trip to Asia where she reports having eaten street food, including pork. If this patient's disease is explained by a parasite that causes inflammation of skeletal muscle, what would be the appropriate treatment?
A. Praziquantel
B. Niridazole
C. Albendazole or mebendazole (Correct Answer)
D. Ivermectin
E. Diethylcarbamazine
Explanation: ***Albendazole or mebendazole***
- The clinical presentation (periorbital edema, myalgia/weakness, eosinophilia, recent travel to Asia with consumption of pork) strongly suggests **trichinellosis**, caused by *Trichinella spiralis*.
- **Albendazole** or **mebendazole** (both benzimidazole anthelmintics) are the drugs of choice for treating trichinellosis by killing adult worms in the intestine and larvae in muscle tissue.
- Treatment is most effective when started early in the course of infection.
*Praziquantel*
- This agent is primarily used to treat infections caused by **trematodes** (flukes) and **cestodes** (tapeworms), such as schistosomiasis and taeniasis.
- It is **not effective** against *Trichinella spiralis*.
*Niridazole*
- Niridazole is an **older antischistosomal drug** that is now rarely used due to significant side effects.
- It has **no activity** against *Trichinella spiralis*.
*Ivermectin*
- Ivermectin is effective against various **nematodes**, including *Onchocerca volvulus* (river blindness) and *Strongyloides stercoralis*.
- While it has some activity against *Trichinella*, it is generally considered less effective than benzimidazoles and **not the first-line treatment** for trichinellosis.
*Diethylcarbamazine*
- This medication is primarily used to treat **lymphatic filariasis** (*Wuchereria bancrofti*, *Brugia malayi*) and **loiasis** (*Loa loa*).
- It is **not effective** against *Trichinella spiralis* infection.
Question 123: A 56-year-old man with a history of HIV presents with diarrhea. The patient has had diarrhea for the past week and it has been gradually worsening. The patient describes it as profuse and watery. He has lost 15 pounds during this time frame and feels very weak. The patient is not currently taking his antiretroviral medications and historically has been non-compliant with his medications. His temperature is 98.5°F (36.9°C), blood pressure is 122/58 mmHg, pulse is 127/min, respirations are 14/min, and oxygen saturation is 99% on room air. Physical exam is notable for an emaciated man who is tachycardic. Stool exam with a modified acid-fast stain reveals organisms. The patient is started on IV fluids. Which of the following is the best treatment for this patient?
A. Nitazoxanide (Correct Answer)
B. Metronidazole
C. Supportive therapy only
D. Mesalamine enema
E. Ciprofloxacin
Explanation: ***Nitazoxanide***
- The patient's presentation with **profuse watery diarrhea**, **weight loss**, and **non-compliance with HIV medications** in an immunosuppressed state, coupled with **acid-fast organisms in stool**, is highly suggestive of **Cryptosporidiosis**.
- While the **most important treatment** for Cryptosporidiosis in HIV patients is **resumption of antiretroviral therapy (ART)** to restore immune function, **Nitazoxanide** is the best **antimicrobial agent** among the options listed.
- Note that Nitazoxanide has **limited efficacy in severely immunocompromised patients** (CD4 <50-100), but it is still recommended as adjunctive therapy along with immune reconstitution.
*Metronidazole*
- This antibiotic is primarily used for anaerobic bacterial infections and parasitic infections such as **Giardia lamblia** and **Entamoeba histolytica**.
- It is **not effective** against Cryptosporidium, which is identified by acid-fast staining.
*Supportive therapy only*
- While **IV fluids** are crucial for rehydration in severe diarrhea and weight loss, supportive care alone is **insufficient** to treat active Cryptosporidium infection in an immunocompromised patient.
- The patient requires both **antimicrobial therapy** and, most importantly, **resumption of ART** for immune reconstitution.
*Mesalamine enema*
- **Mesalamine enemas** are anti-inflammatory medications used to treat inflammatory bowel diseases like **ulcerative colitis**, particularly in the rectum and lower colon.
- They are **not indicated** for infectious diarrhea caused by parasites like Cryptosporidium.
*Ciprofloxacin*
- **Ciprofloxacin** is a fluoroquinolone antibiotic used for bacterial infections, including some causes of bacterial gastroenteritis.
- It is **ineffective** against parasitic infections such as Cryptosporidiosis.
Question 124: A 62-year-old woman presents to her oncologist to discuss the chemotherapy options for her newly diagnosed breast cancer. During the meeting, they discuss a drug that inhibits the breakdown of mitotic spindles in cells. Her oncologist explains that this will be more toxic to cancer cells because those cells are dividing more rapidly. Which of the following side effects is closely associated with the use of this chemotherapeutic agent?
A. Photosensitivity
B. Peripheral neuropathy (Correct Answer)
C. Paralytic ileus
D. Hemorrhagic cystitis
E. Pulmonary fibrosis
Explanation: ***Peripheral neuropathy***
- Drugs that inhibit the breakdown of **mitotic spindles** are **microtubule-targeting agents** (e.g., **taxanes** like paclitaxel/docetaxel, **vinca alkaloids** like vincristine/vinblastine).
- These agents interfere with **microtubule function** in neurons, leading to **axonal damage** and **peripheral neuropathy**.
- This is the **most characteristic and common dose-limiting toxicity** of microtubule inhibitors, affecting sensory and motor nerves (numbness, tingling, weakness in extremities).
*Photosensitivity*
- **Photosensitivity** is a common adverse effect associated with certain chemotherapeutic agents like **fluorouracil** (5-FU) or **methotrexate**, but is not linked to microtubule inhibitors.
- It involves an increased sensitivity to UV light, often manifesting as a rash or exaggerated sunburn.
*Paralytic ileus*
- **Paralytic ileus** can occur with **vinca alkaloids** (especially vincristine) due to autonomic neuropathy affecting the **enteric nervous system**.
- However, this is **less common** than peripheral neuropathy and occurs more specifically with vincristine rather than taxanes.
- **Peripheral neuropathy** is the more pervasive, dose-limiting, and universally characteristic side effect across all microtubule inhibitors.
*Hemorrhagic cystitis*
- **Hemorrhagic cystitis** is a classic side effect of **alkylating agents** like **cyclophosphamide** and **ifosfamide**, which produce the toxic metabolite **acrolein**.
- It is prevented/managed with **mesna**, which inactivates acrolein.
- Not associated with microtubule inhibitors.
*Pulmonary fibrosis*
- **Pulmonary fibrosis** is a known side effect of certain chemotherapeutic drugs, most notably **bleomycin** and **busulfan**.
- This adverse effect is not associated with agents that target **mitotic spindle breakdown**.
Question 125: A 32-year-old female presents to her gynecologist complaining of heavy and irregular vaginal bleeding. One month ago, she underwent a dilation and curettage procedure to remove a hydatidiform mole. On examination, her uterus appears enlarged. Serum ß-hCG is highly elevated. Biopsy of her uterus reveals avillous proliferation of cytotrophoblasts and syncytiotrophoblasts. She is eventually diagnosed with choriocarcinoma and initiates treatment with a medication known to affect folate metabolism. Which of the following complications should this patient most likely be monitored for following initiation of the medication?
A. Hemorrhagic cystitis
B. Pulmonary fibrosis
C. Peripheral neuropathy
D. Cardiotoxicity
E. Bone marrow suppression (Correct Answer)
Explanation: ***Bone marrow suppression***
- The medication affecting folate metabolism used for choriocarcinoma is **methotrexate**, a folate antagonist that inhibits dihydrofolate reductase.
- **Myelosuppression (bone marrow suppression)** is the **most common and clinically significant dose-limiting toxicity** of methotrexate, manifesting as pancytopenia with decreased white blood cells, red blood cells, and platelets.
- Patients on methotrexate require **routine complete blood count (CBC) monitoring** before and during treatment to detect myelosuppression early.
- Other important methotrexate toxicities include hepatotoxicity, nephrotoxicity, and mucositis, but bone marrow suppression is the primary concern requiring close monitoring.
*Pulmonary fibrosis*
- While methotrexate can rarely cause pulmonary toxicity, it typically presents as **acute pneumonitis** (hypersensitivity reaction) rather than chronic fibrosis.
- Pulmonary toxicity occurs in <10% of patients and is more commonly associated with chronic low-dose methotrexate use (e.g., for rheumatoid arthritis) than high-dose chemotherapy.
- This is not the most likely complication requiring routine monitoring.
*Hemorrhagic cystitis*
- **Hemorrhagic cystitis** is a characteristic complication of **cyclophosphamide** and **ifosfamide**, not methotrexate.
- It results from toxic metabolite (acrolein) accumulation in the bladder and can be prevented with hydration and mesna.
*Peripheral neuropathy*
- **Peripheral neuropathy** is typically associated with **vinca alkaloids** (vincristine, vinblastine) and **taxanes** (paclitaxel, docetaxel), which disrupt microtubule function.
- Methotrexate does not cause peripheral neuropathy as a primary toxicity.
*Cardiotoxicity*
- **Cardiotoxicity**, including dilated cardiomyopathy, is a well-known dose-dependent complication of **anthracyclines** (doxorubicin, daunorubicin).
- Methotrexate is not associated with direct cardiac toxicity.
Question 126: A 67-year-old woman who was diagnosed with cancer 2 months ago presents to her oncologist with a 6-day history of numbness and tingling in her hands and feet. She is concerned that these symptoms may be related to progression of her cancer even though she has been faithfully following her chemotherapy regimen. She is not currently taking any other medications and has never previously experienced these symptoms. On physical exam, she is found to have decreased sensation to pinprick and fine touch over hands, wrists, ankles, and feet. Furthermore, she is found to have decreased reflexes throughout. Her oncologist assures her that these symptoms are a side effect from her chemotherapy regimen rather than progression of the cancer. The drug most likely responsible for her symptoms has which of the following mechanisms?
A. Alkylation of DNA
B. Inhibit folate metabolism
C. DNA strand breaking
D. Inhibit microtubule formation (Correct Answer)
E. Prevention of nucleotide synthesis
Explanation: ***Inhibit microtubule formation***
- The patient's symptoms of **numbness**, **tingling**, **decreased sensation** to pinprick and fine touch in a **stocking-glove distribution**, and **decreased reflexes** are characteristic of **peripheral neuropathy**.
- **Vinca alkaloids** (e.g., vincristine) and **taxanes** (e.g., paclitaxel, docetaxel) are chemotherapy agents that **inhibit microtubule formation**, and **peripheral neuropathy is their classic dose-limiting toxicity**.
- These agents are the **most strongly associated** with this specific adverse effect pattern among chemotherapy drugs.
*Alkylation of DNA*
- **Alkylating agents** (e.g., cyclophosphamide) and **platinum-based agents** (e.g., cisplatin, oxaliplatin) exert their cytotoxic effects by **cross-linking DNA strands**, preventing DNA replication and transcription.
- While **cisplatin and oxaliplatin can cause significant peripheral neuropathy**, the **microtubule inhibitors** (vinca alkaloids and taxanes) are **more classically associated** with this side effect and are the expected answer in this clinical context.
*Inhibit folate metabolism*
- This mechanism is characteristic of **antimetabolites** like **methotrexate**, which **inhibits dihydrofolate reductase**, thereby disrupting DNA synthesis.
- While methotrexate can have neurological side effects (particularly intrathecal administration causing neurotoxicity), **typical peripheral neuropathy is not its most common or direct adverse effect** related to this mechanism.
*DNA strand breaking*
- This mechanism is associated with agents like **etoposide** (a topoisomerase inhibitor) or **bleomycin** (which generates free radicals causing DNA strand breaks).
- While these drugs have various toxicities, they are **not typically associated with peripheral neuropathy** as their primary or most prominent side effect.
*Prevention of nucleotide synthesis*
- This is a broad mechanism shared by many **antimetabolites** (e.g., 5-fluorouracil, hydroxyurea, cytarabine) that interfere with the synthesis of purines or pyrimidines.
- While these agents can cause various adverse effects, **peripheral neuropathy is not a hallmark toxicity** as it is with drugs that target microtubules.
Question 127: A 69-year-old male with past medical history of hypertension, hyperlipidemia, and diabetes mellitus complicated by end stage renal disease on dialysis presents to his nephrologist for a follow-up appointment. A few weeks ago, the patient saw his nephrologist because he had been feeling tired despite efforts to get enough sleep, eat a well-balanced diet, and exercise. At the time, laboratory studies revealed a hemoglobin of 9.7 g/dL, and the patient’s nephrologist suggested starting recombinant human erythropoietin (EPO). Since then, the patient has been receiving EPO intravenously three times per week. The patient reports today that he continues to feel tired despite the new treatment. His temperature is 98.0°F (36.7°C), blood pressure is 134/83 mmHg, pulse is 65/min, and respirations are 12/min. On physical exam, he has conjunctival pallor, and laboratory studies show a hemoglobin of 9.8 g/dL.
Which of the following laboratory findings would currently be seen in this patient?
A. Normal MCV, increased RDW, increased ferritin, increased transferrin saturation
B. Low MCV, increased RDW, increased ferritin, decreased transferrin saturation
C. Low MCV, increased RDW, normal ferritin, normal transferrin saturation
D. Normal MCV, normal RDW, increased ferritin, increased transferrin saturation
Explanation: ***Low MCV, increased RDW, decreased ferritin, decreased transferrin saturation***
- The patient's persistent anemia despite **erythropoietin (EPO)** treatment, along with conjunctival pallor and an unchanged hemoglobin level, points towards an underlying **iron deficiency**.
- **Iron deficiency** is characterized by **microcytic (low MCV)**, **hypochromic** red blood cells, often with an **increased red cell distribution width (RDW)** due to varying cell sizes, and labs showing **decreased ferritin** (iron stores) and **decreased transferrin saturation** (iron transport).
*Normal MCV, increased RDW, increased ferritin, increased transferrin saturation*
- This profile (**increased ferritin** and **transferrin saturation**) is inconsistent with **iron deficiency**, which is the likely cause of the patient's persistent anemia despite EPO.
- While an **increased RDW** can be seen in some anemias, the other markers do not fit the clinical picture of uncorrected anemia.
*Low MCV, increased RDW, increased ferritin, decreased transferrin saturation*
- The presence of **increased ferritin** suggests sufficient or even elevated iron stores, which contradicts the classic picture of **iron deficiency anemia**.
- **Decreased transferrin saturation** with **increased ferritin** can occur in **anemia of chronic disease (ACD)**, but the primary issue here is likely iron deficiency given the patient's ESRD and lack of response to EPO.
*Low MCV, increased RDW, normal ferritin, normal transferrin saturation*
- **Normal ferritin** and **normal transferrin saturation** would typically rule out **iron deficiency anemia** as the cause of microcytic anemia.
- In a patient with end-stage renal disease (ESRD) and uncorrected anemia, **iron deficiency** is a common and often co-existing issue, making normal iron studies unlikely if iron deficiency is the problem.
*Normal MCV, normal RDW, increased ferritin, increased transferrin saturation*
- This profile suggests **adequate iron stores** and typically indicates a **normocytic anemia** (normal MCV) without significant variation in red cell size (normal RDW).
- Given the patient's uncorrected anemia and the need for EPO, this laboratory picture does not align with the most likely cause of continued fatigue, which is an **iron deficiency**.
Question 128: A 23-year-old man is admitted to the hospital for observation because of a headache, dizziness, and nausea that started earlier in the day while he was working. He moves supplies for a refrigeration company and was handling a barrel of carbon tetrachloride before the symptoms began. He was not wearing a mask. One day after admission, he develops a fever and is confused. His temperature is 38.4°C (101.1°F). Serum studies show a creatinine concentration of 2.0 mg/dL and alanine aminotransferase concentration of 96 U/L. This patient's laboratory abnormalities are most likely due to which of the following processes?
A. Metabolite haptenization
B. Lipid peroxidation (Correct Answer)
C. Microtubule stabilization
D. Protoporphyrin accumulation
E. Glutathione depletion
Explanation: ***Lipid peroxidation***
- **Carbon tetrachloride (CCl4)** poisoning primarily causes liver and kidney damage through the formation of **CCl3• radical**, which triggers **lipid peroxidation** of cellular membranes.
- This process leads to irreversible cell damage, manifesting as elevated liver enzymes (ALT) and kidney dysfunction (creatinine).
- Lipid peroxidation is the **direct mechanism of cellular injury**, causing membrane disruption, organelle dysfunction, and cell death.
*Metabolite haptenization*
- While some toxins form **haptens** that can lead to immune-mediated injury, the primary mechanism of CCl4 toxicity is direct cellular damage via free radicals, not haptenization.
- Haptenization typically involves a delayed hypersensitivity reaction, which is not the immediate and severe organ damage seen with CCl4.
*Microtubule stabilization*
- **Microtubule stabilization** is a mechanism of action for certain drugs (e.g., taxanes in chemotherapy) that interfere with cell division, but it is not a direct mechanism of toxicity for CCl4.
- CCl4 toxicity is characterized by membrane damage, not disruption of the cytoskeleton.
*Protoporphyrin accumulation*
- **Protoporphyrin accumulation** is characteristic of certain **porphyrias** or **lead poisoning**, where there are defects in heme synthesis.
- This mechanism is unrelated to the direct oxidative damage caused by CCl4 and its free radical metabolites.
*Glutathione depletion*
- **Glutathione (GSH)** depletion occurs early in CCl4 toxicity, reducing the cell's antioxidant capacity and allowing free radical accumulation.
- However, GSH depletion is an **upstream event** that facilitates damage, while **lipid peroxidation** is the **downstream direct mechanism** that actually destroys cellular membranes and causes organ injury.
- The question asks for the process causing the laboratory abnormalities (liver and kidney damage), making lipid peroxidation the more direct and accurate answer.
Question 129: A 15-year-old boy presents to the emergency department after a rusty nail pierced through his right foot. He was able to pull out the nail, but is unable to walk on his foot. He believes he had all his shots as a child, but his mother is unsure and cannot recall the specific vaccination dates or details. His last documented tetanus vaccination was at age 12. The vital signs are within normal limits. Physical examination reveals a 0.5-inch puncture wound on the right heel. The site is tender, erythematous, with flecks of reddish-brown particles in the base. No blood or discharge is seen. Which of the following is the most appropriate next step in management?
A. Administer DT
B. Administer Td only
C. Clean and dress the wound only
D. Administer Td and TIG (Correct Answer)
E. Administer Tdap, Td, and TIG (tetanus immune globulin)
Explanation: ***Administer Td and TIG***
- This patient has a **dirty wound** (rusty nail, reddish-brown particles indicating contamination) with **uncertain immunization history** (mother cannot recall vaccination details or confirm completion of primary series).
- Although the last documented tetanus vaccination was at age 12 (3 years ago), the **uncertainty about whether the primary vaccination series was completed** necessitates treating this as an incomplete immunization history.
- For dirty wounds with uncertain/incomplete immunization history, both **Td (active immunity)** and **Tetanus Immune Globulin/TIG (immediate passive immunity)** are required per CDC guidelines.
- TIG provides immediate protection against circulating tetanus toxin while Td stimulates the patient's own immune response.
*Administer DT*
- **DT** (diphtheria and tetanus toxoids) is formulated for children **younger than 7 years old**.
- This patient is 15 years old, so **Td** (adult formulation with reduced diphtheria component) is the appropriate vaccine.
*Administer Td only*
- While a **Td booster** addresses active immunity, it takes **2-4 weeks** to produce protective antibody levels.
- For a **high-risk dirty wound with uncertain immunization history**, this delayed protection is insufficient.
- **TIG is essential** to provide immediate passive immunity and neutralize any tetanus toxin that may be produced before the Td vaccine becomes effective.
*Clean and dress the wound only*
- **Wound care** (cleaning, irrigation, debridement of devitalized tissue) is essential but **insufficient** as sole management.
- Given the high-risk wound and uncertain immunization history, **tetanus prophylaxis is mandatory** to prevent potentially fatal tetanus infection.
*Administer Tdap, Td, and TIG (tetanus immune globulin)*
- Administering both **Tdap and Td simultaneously is redundant** and not recommended.
- **Tdap** (which includes pertussis) can be used instead of Td for wound prophylaxis if the patient has never received Tdap, but giving both Tdap AND Td is unnecessary.
- While TIG is appropriate for this scenario, the dual vaccine administration (Tdap + Td) is **not standard practice**.
Question 130: A 65-year-old man comes to the physician because of a 1-month history of progressive back pain. He has also had a 5-kg (11-lb) weight loss over the past 3 months. His only medications are a daily multivitamin and ibuprofen, which he takes daily for the back pain. Physical examination shows tenderness to palpation over the lower spine and the left iliac crest. His hemoglobin concentration is 9.3 g/dL, his serum calcium concentration is 12 mg/dL, and his serum creatinine concentration is 2.1 mg/dL. A bone marrow biopsy shows 21% plasma cells. A diagnosis of multiple myeloma is established. In preparation for an autologous hematopoietic stem cell transplantation, the patient receives a myeloablative treatment regimen that includes busulfan. Which of the following drugs acts via a similar mechanism of action to busulfan?
A. Etoposide
B. Vemurafenib
C. Vincristine
D. Cytarabine
E. Lomustine (Correct Answer)
Explanation: ***Lomustine***
- Both **busulfan** and **lomustine** are **alkylating agents**. They act by transferring **alkyl groups** to DNA, leading to cross-linking of DNA strands and inhibition of DNA synthesis and function.
- This **DNA damage** results in cell cycle arrest and apoptosis, particularly in rapidly dividing cells like cancer cells.
*Etoposide*
- **Etoposide** is a **topoisomerase II inhibitor** that prevents DNA relegation after strand breaks, leading to DNA damage and cell death.
- While it also targets DNA, its mechanism is distinct from the alkylation process of busulfan.
*Vemurafenib*
- **Vemurafenib** is a **BRAF kinase inhibitor** used in melanoma treatment. It specifically targets the **BRAF V600E mutation**.
- Its mechanism involves blocking signal transduction pathways critical for cell proliferation, rather than directly damaging DNA.
*Vincristine*
- **Vincristine** is a **vinca alkaloid** that acts as a **microtubule inhibitor**, preventing the formation of the **mitotic spindle** during cell division.
- This leads to metaphase arrest and apoptosis, a mechanism fundamentally different from DNA alkylation.
*Cytarabine*
- **Cytarabine** is an **antimetabolite**, specifically a **pyrimidine analog**, that inhibits **DNA polymerase**.
- It gets incorporated into DNA, leading to chain termination and inhibition of DNA synthesis and repair, making its action different from direct DNA alkylation.
